Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 7/20 | 0.79 |
| ▸ | APEX1 | P27695 | 3/20 | 0.79 |
| ▸ | APAF1 | O14727 | 2/20 | 0.79 |
| ▸ | LMNA | P02545 | 2/20 | 0.79 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.79 |
| ▸ | TSHR | P16473 | 1/20 | 0.79 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.79 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.79 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.79 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.78 |
| ▸ | MMP2 | P08253 | 1/20 | 0.78 |
| ▸ | MAPT | P10636 | 5/20 | 0.69 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.69 |
| ▸ | CNR1 | P21554 | 1/20 | 0.69 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.69 |
| ▸ | NR1I2 | O75469 | 6/20 | 0.59 |
| ▸ | HTR2C | P28335 | 1/20 | 0.59 |
| ▸ | PPARG | P37231 | 2/20 | 0.58 |
| ▸ | ALB | P02768 | 1/20 | 0.58 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12374915 | 0.94 | TDP1 (0.77) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| SCHEMBL15291405 | 0.89 | TDP1 (0.86) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| Cefixime SCHEMBL3553107 | 0.88 | TDP1 (1.00) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| Cefixime SCHEMBL4812946 | 0.88 | TDP1 (1.00) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| Cefixime SCHEMBL49534 | 0.88 | TDP1 (1.00) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| Cefixime SCHEMBL16072825 | 0.88 | TDP1 (1.00) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| Cefixime SCHEMBL3553111 | 0.88 | TDP1 (1.00) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| Cefixime SCHEMBL9483204 | 0.88 | TDP1 (1.00) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| Cefixime SCHEMBL17131963 | 0.88 | TDP1 (1.00) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| Cefixime SCHEMBL4812929 | 0.88 | TDP1 (1.00) | TDP1APEX1APAF1LMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7427600-B2 | Active agent delivery systems and methods for protecting and administering active agents | SHIRE LLC (US) | 2008-09-23 | — | — | US | disclosed |
| US-20070232529-A1 | mesalamine covalently attached to carrier peptide at C-terminus, interspersed and/or side chain; releasing into bloodstream; reducing dosage | NEW RIVER PHARMACEUTICALS INC. (US) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232529-A1 | mesalamine covalently attached to carrier peptide at C-terminus, interspersed and/or side chain; releasing into bloodstream; reducing dosage | VIP, BST2, FCGR3B | TDP1 4048/4885APEX1 791/4885APAF1 1586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.